SalioGen Therapeutics Announces Data Presentations at 2024 Annual Meetings for the Association for Research in Vision ...
--Company to present pre-clinical data on Stargardt disease development candidate SGT-1001-- --New in vitro data demonstrate site-specific integration of CFTR, a potential mutation-agnostic treatment approach for cystic fibrosis-- LEXINGTON, Mass., April …